Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

ClinicalTrials.gov ID: NCT00784719

Public ClinicalTrials.gov record NCT00784719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Prospective, Randomized, Double Masked, Vehicle And Comparator Controlled, Dose Ranging Study Of CP-690,550 In Subjects With Dry Eye Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.

Study identification

NCT ID
NCT00784719
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
327 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2008 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Apr 9, 2013

2008 – 2009

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Pfizer Investigational Site Chandler Arizona 85286 —
Pfizer Investigational Site Peoria Arizona 85381 —
Pfizer Investigational Site Phoenix Arizona 85032 —
Pfizer Investigational Site Artesia California 90701 —
Pfizer Investigational Site Centennial Colorado 80112 —
Pfizer Investigational Site Ormond Beach Florida 32174 —
Pfizer Investigational Site Stuart Florida 34994 —
Pfizer Investigational Site Tamarac Florida 33321 —
Pfizer Investigational Site Tampa Florida 33603 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Morrow Georgia 30260 —
Pfizer Investigational Site Roswell Georgia 30076 —
Pfizer Investigational Site Louisville Kentucky 40217 —
Pfizer Investigational Site Baltimore Maryland 21287 —
Pfizer Investigational Site Boston Massachusetts 02114 —
Pfizer Investigational Site Kansas City Missouri 64111 —
Pfizer Investigational Site Lynbrook New York 11563 —
Pfizer Investigational Site Rochester New York 14618 —
Pfizer Investigational Site Charlotte North Carolina 28210 —
Pfizer Investigational Site High Point North Carolina 27262 —
Pfizer Investigational Site Cleveland Ohio 44115 —
Pfizer Investigational Site Columbus Ohio 43210 —
Pfizer Investigational Site Memphis Tennessee 38119 —
Pfizer Investigational Site Austin Texas 78705 —
Pfizer Investigational Site Austin Texas 78731 —
Pfizer Investigational Site Austin Texas 78746 —
Pfizer Investigational Site San Antonio Texas 78240 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00784719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2013 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00784719 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →